Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
RSV, Canada and Moderna
Canada approves Moderna's RSV vaccine for those age 60 and older, company says
Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus, or
RSV
, in adults 60 years and older, making it the country's first authorized mRNA-based shot for the condition. Health Canada has approved the ...
Canada approves Moderna's RSV vaccine for adults aged 60 and older
Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years and older, making it the country's first authorised mRNA-based shot for the condition.
Moderna receives Health Canada approval for RSV vaccine for 60 years, older
Moderna (MRNA) announced Health Canada has approved mRESVIA for active immunization for the prevention of lower respiratory tract disease caused by respiratory syncytial virus in adults 60 years of age and older mRESVIA is the only
RSV
vaccine available in ...
RSV Vaccine 90% Effective in High-Risk Adults, Real-World Study Shows
The bivalent RSV prefusion F vaccine (Abrysvo) demonstrated 90% vaccine effectiveness (VE) in high-risk adults against hospitalizations or emergency department (ED) visits associated with respiratory syncytial virus (RSV), according to recent real-world data presented at the IDWeek annual meeting in Los Angeles.
Health Canada approves Moderna's mRNA RSV vaccine, company says
Moderna says Health Canada has approved its mRNA vaccine to protect against respiratory syncytial virus in adults age 60 and older.
5d
Everything You Need To Know About RSV This Fall
RSV season is upon us, which means thousands of children under five years of age and hundreds of thousands of adults will be ...
Hosted on MSN
1d
Year in Review: RSV
This year's headlines on respiratory syncytial virus (
RSV
) focused largely on the relatively new vaccines -- including a ...
FiercePharma
1d
Moderna disappoints in RSV debut, squares up with Pfizer in COVID-19 vaccine sales
Days after Pfizer and BioNTech reported surprisingly strong sales of their updated COVID-19 vaccines, Moderna has done the ...
Glamour on MSN
5d
RSV Symptoms: Here’s How the Virus Shows Up Differently in Babies, Adults, and Seniors
Just like adults under 60, elderly adults who get RSV tend to have mild symptoms, such as runny nose, sore throat, cough, ...
BioSpace
1d
Moderna Gets Better-Than-Expected Q3 COVID-19 Vaccine Sales, but RSV Shot Disappoints
While Moderna’s Spikevax beat Wall Street estimates in the third quarter, William Blair analyst Myles Minter in a Thursday ...
3d
Canada approves GSK's RSV vaccine for adults aged 50 to 59
GSK has received Canadian approval for its respiratory syncytial virus vaccine in adults between 50 and 59, the company said ...
BlackDoctor
3d
Doctor & Mom Shares What Every Parent Needs to Know About RSV This Winter
Dr. Kerry-Anne Perkins, a new mom and board-certified OB-GYN shares what parents need to know about RSV and more.
10h
on MSN
Doctors stress the importance of the RSV vaccine
With cold and flu season around the corner, Doctors recommend receiving the RSV vaccine ahead of the holidays.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Canada
Moderna
Pfizer
GlaxoSmithKline
Arexvy
Feedback